StatPearls, LLC

  • Constriction, Pathologic
  • Headache
  • Ischemic Stroke
  • Moyamoya Disease
  • Seizures

Moyamoya Disease

Moyamoya disease is a progressive cerebrovascular disorder marked by stenosis or occlusion at the terminal portion of the internal carotid arteries and the formation of fragile collateral vessels, often described as a “puff of smoke” on angiography. While initially described in Japan in the late 1950s, its clinical and radiographic recognition has since expanded globally. This course offers an in-depth review of moyamoya disease and syndrome, highlighting key distinctions in presentation between pediatric and adult populations, including ischemic strokes, TIAs, hemorrhagic events, seizures, headaches, and cognitive or psychiatric symptoms. Learners will explore the roles of advanced imaging in diagnosis, staging, and perioperative planning. Surgical revascularization remains the cornerstone of treatment, and the session outlines both direct and indirect approaches, alongside anesthesia and postoperative management considerations critical to reducing ischemic complications. Medical therapy, while limited in halting disease progression, plays an adjunctive role in symptom control and stroke prevention. This activity for healthcare professionals is designed to enhance the learner’s competence in identifying moyamoya disease, performing the recommended evaluation and risk stratification, and implementing an appropriate interprofessional approach when managing this condition to improve patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left